Last Updated: 02/12/2025
Understanding a novel immune approach for malaria control and the implications for a vaccine
Objectives
This research program will unravel the mechanisms by which Mucosal-associated invariant T cells (MAIT cells), a recently identified set of innate-like T cells, contribute to protection from malaria.
Malaria remains one of the deadliest infectious diseases worldwide. This research program is expected to provide entirely new insights on protective immunity to malaria and substantially advance fundamental knowledge in the emerging MAIT cell field. It will also develop new MAIT cell-based vaccines against malaria.
Jan 2026 — Dec 2029
$1.05M


